Susquehanna International Group
AKCA

Susquehanna International Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Susquehanna International Group’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,800
Closed -$353K – 11453
2020
Q2 		$353K Buy
25,800
+12,700
+97% +$196K ﹤0.01% 8062
2020
Q1 		$187K Sell
13,100
-4,800
-27% -$78.8K ﹤0.01% 8773
2019
Q4 		$303K Sell
17,900
-190,200
-91% -$3.54M ﹤0.01% 8001
2019
Q3 		$3.2M Sell
208,100
-12,300
-6% -$262K ﹤0.01% 3390
2019
Q2 		$5.17M Buy
220,400
+10,400
+5% +$257K ﹤0.01% 2664
2019
Q1 		$5.95M Buy
210,000
+95,100
+83% +$2.77M ﹤0.01% 2259
2018
Q4 		$3.46M Buy
114,900
+22,000
+24% +$617K ﹤0.01% 2726
2018
Q3 		$3.25M Buy
92,900
+60,700
+189% +$1.84M ﹤0.01% 3247
2018
Q2 		$763K Buy
32,200
+11,500
+56% +$275K ﹤0.01% 5944
2018
Q1 		$530K Buy
+20,700
New +$446K ﹤0.01% 6514

Susquehanna International Group's AKCA Position: Q2 2020 in Review

Susquehanna International Group sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 33,430 shares — an estimated $516K sold.

Susquehanna International Group first reported a position in AKCA in Q2 2019 and held it in 3 quarters. The position peaked at $1.03M in Q4 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

  • Susquehanna International Group reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 33,430 Akcea Therapeutics Inc shares in Q2 2020, an estimated $516K.
  • Susquehanna International Group first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 3 quarters.
  • Susquehanna International Group's Akcea Therapeutics Inc position peaked at $1.03M in Q4 2019.
  • 84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.